Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
TDP-43相关神经变性中LINE1 RNA的调控机制和功能基因组学
基本信息
- 批准号:10518877
- 负责人:
- 金额:$ 87.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-15 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:ALS patientsAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAmyotrophic Lateral SclerosisAutopsyC9ORF72ChromatinClustered Regularly Interspaced Short Palindromic RepeatsDNADNA DamageDataDegradation PathwayDevelopmentDiseaseElementsEuchromatinEventFamilyFeedbackFrontotemporal DementiaFunctional disorderGene ExpressionGenesGeneticGenetic TranscriptionGenomeGenomic approachGenomicsGoalsHumanHuman GenomeLengthLinkMediatingMessenger RNAMobile Genetic ElementsModificationMolecularMusNerve DegenerationNeurodegenerative DisordersNeuronsNuclearPathologicPathologyPathway interactionsPatientsPlayPoint MutationProcessRNARNA DecayRNA DegradationRNA ProcessingRNA SplicingRNA metabolismRNA-Binding ProteinsRegulationRelaxationReportingResearch Project GrantsRetroelementsRetrotranspositionRetrotransposonReverse Transcriptase InhibitorsRoleSiteTechniquesTissuesTranscriptTranscriptional ActivationUntranslated RNAUp-Regulationembryonic stem cellfunctional genomicsgene networkgenome-widegenomic locushistone modificationimprovedinduced pluripotent stem cellinterestknock-downloss of functionprotein TDP-43stem cell differentiationtherapy development
项目摘要
Dysfunction of RNA metabolism has emerged to play crucial roles in multiple neurodegeneration diseases, including Alzheimer’s Disease (AD) and Alzheimer’s Disease related dementias (ADRD), such as frontal temporal dementia (FTD). One pathologic hallmark of these diseases is the nuclear clearance and cytosolic aggregation of the RNA binding protein (RBP) TAR DNA binding protein-43 (TDP-43), which is found in 20-60% AD patients and 50% FTD patients. TDP-43 has multiple functions in mRNA processing. It is also implicated in regulating retrotransposon activation, but the molecular mechanism is not resolved.
Retrotransposon elements are mobile genetic elements that copy themselves by transcribing into RNA, reverse-transcribed into DNA and then inserted into new sites in the genome, a process known as retrotransposition. Long interspersed nuclear element-1 (LINE1) is the only currently active, autonomous family of retrotransposon elements in human, and accounts for ~20% of the human genome. Only a small subset of LINE1s are thought to be mobile. The majority are inactive due to truncations, rearrangements and point mutations. There are increasing interest in understanding the “noncoding RNA” functions of LINE1 RNA in chromatin state regulation.
In this research project, we will decipher the molecular mechanism of LINE1 RNA dysregulation, particularly the dysfunction of LINE1 RNA decay pathway caused by TDP-43 loss of function, which is associated with the pathology of Alzheimer’s Disease and Alzheimer’s Disease Related Dementias. We will determine the causal relationship of LINE1 RNA elevation with chromatin accessibility, histone modification and transcriptional gene network disruption. We will combine human induced pluripotent stem cell-differentiated neurons and postmortem tissues from AD and FTD patients to dissect the molecular mechanisms associated with TDP-43 proteiopathy. Our proposed study will provide deeper mechanistic understanding of the retroelement dysregulation in AD/ADRD and its role in functional genomics, which is largely understudied in the past. The findings will help understanding disease mechanisms and facilitating therapy development for Alzheimer’s Disease and Alzheimer’s Disease Related Dementias.
RNA代谢功能障碍已出现在包括阿尔茨海默氏病(AD)和阿尔茨海默氏病有关的多种神经变性疾病中起关键作用,例如额叶临时痴呆症(FTD)。这些疾病的一个病理标志是RNA结合蛋白(RBP)TAR DNA结合蛋白-43(TDP-43)的核清除和胞质聚集,这在20-60%的AD AD患者和50%的FTD患者中发现。 TDP-43在mRNA处理中具有多个功能。它也与控制返回跨座子激活有关,但分子机制尚未解决。
逆转录元素元素是移动遗传元件,通过转录RNA,反转录到DNA中,然后插入基因组中的新位点,该过程被称为逆转录词。长期散布的核元素-1(LINE1)是人类中唯一活跃的逆转录元元素的自主家族,占人类基因组的约20%。只有一小部分LINE1被认为是移动的。由于截断,重排和点突变,大多数是无效的。在理解染色质状态调节中LINE1 RNA的“非编码RNA”功能的兴趣越来越大。
在该研究项目中,我们将解释LINE1 RNA失调的分子机制,特别是TDP-43功能丧失引起的Line1 RNA衰变途径的功能障碍,这与阿尔茨海默氏病和阿尔茨海默氏病有关的病理学有关。我们将确定Line1 RNA升高与染色质可及性,组蛋白修饰和转录基因网络破坏的因果关系。我们将结合人类诱导的多能干细胞分化的神经元和来自AD和FTD患者的死后组织,以剖析与TDP-43蛋白质病有关的分子机制。我们提出的研究将对AD/ADRD的追溯失调及其在功能基因组中的作用提供更深入的机械理解,这在过去很大程度上被理解了。这些发现将有助于了解阿尔茨海默氏病和阿尔茨海默氏病与痴呆症相关的疾病机制并促进治疗发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xianjun Dong其他文献
Xianjun Dong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xianjun Dong', 18)}}的其他基金
A Large-scale Extracellular Vesicle RNA-seq Resource for Parkinsons Disease
帕金森病的大规模细胞外囊泡 RNA-seq 资源
- 批准号:
10706937 - 财政年份:2023
- 资助金额:
$ 87.74万 - 项目类别:
Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
TDP-43相关神经变性中LINE1 RNA的调控机制和功能基因组学
- 批准号:
10697326 - 财政年份:2022
- 资助金额:
$ 87.74万 - 项目类别:
Systematic study of extracellular vesicles and their integrative analysis with Parkinson's organoids MAP
细胞外囊泡的系统研究及其与帕金森氏类器官 MAP 的综合分析
- 批准号:
10345089 - 财政年份:2022
- 资助金额:
$ 87.74万 - 项目类别:
Systematic Study of Extracellular Vesicles and their Integrative Analysis with Parkinson's Organoids MAP
细胞外囊泡的系统研究及其与帕金森氏类器官 MAP 的综合分析
- 批准号:
10605192 - 财政年份:2022
- 资助金额:
$ 87.74万 - 项目类别:
AI2AMP-PD: Accelerating Parkinsons Diagnosis using Multi-omics and Artificial Intelligence
AI2AMP-PD:利用多组学和人工智能加速帕金森病诊断
- 批准号:
10157680 - 财政年份:2020
- 资助金额:
$ 87.74万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Regulation of paraspeckles by STAU1 in neurodegenerative disease
STAU1 在神经退行性疾病中对 paraspeckles 的调节
- 批准号:
10668027 - 财政年份:2023
- 资助金额:
$ 87.74万 - 项目类别:
Investigating the Role of MS4As in Amyotrophic Lateral Sclerosis
研究 MS4As 在肌萎缩侧索硬化症中的作用
- 批准号:
10751695 - 财政年份:2023
- 资助金额:
$ 87.74万 - 项目类别:
Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
TDP-43相关神经变性中LINE1 RNA的调控机制和功能基因组学
- 批准号:
10697326 - 财政年份:2022
- 资助金额:
$ 87.74万 - 项目类别:
Effects of TDP-43 Proteinopathy on Retrotransposon Activation and Cell-Type Specific Vulnerability in a Mammalian Model of Alzheimer's and Related Dementias
TDP-43 蛋白病对阿尔茨海默病和相关痴呆哺乳动物模型中逆转录转座子激活和细胞类型特异性脆弱性的影响
- 批准号:
10560868 - 财政年份:2022
- 资助金额:
$ 87.74万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10587736 - 财政年份:2022
- 资助金额:
$ 87.74万 - 项目类别: